Elanco Animal Health (ELAN) Depreciation and Depletion (2024 - 2026)
Elanco Animal Health's (ELAN) quarterly Depreciation and Depletion came in at $28.0 million in Q1 2026, up 16.67% year-on-year from $24.0 million in Q1 2025, and little changed quarter-over-quarter from $28.0 million in Q3 2025.
Elanco Animal Health (ELAN) Depreciation and Depletion (2024 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $28.0 million for Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $28.0 million, up 16.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $105.0 million (up 8.25% YoY), and the FY2024 annual result was $95.0 million, up 3.26% from the prior year.
- Depreciation and Depletion came in at $28.0 million for Q1 2026 at Elanco Animal Health, roughly flat from $28.0 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $28.0 million in Q3 2025 to a low of $22.0 million in Q1 2024.
- The 3-year median for Depreciation and Depletion is $24.5 million (2024), against an average of $25.0 million.
- Across the five-year window, Depreciation and Depletion advanced 3.7% in 2025 and grew 16.67% in 2026, its largest moves.
- Elanco Animal Health's Depreciation and Depletion stood at $24.0 million in 2024, then grew by 16.67% to $28.0 million in 2025, then changed by 0.0% to $28.0 million in 2026.
- The last three Depreciation and Depletion figures came in at $28.0 million (Q1 2026), $28.0 million (Q3 2025), and $25.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.00 Mn |
| Mar 31, 2026 | 28.00 Mn |
| Sep 30, 2025 | 28.00 Mn |
| Sep 30, 2025 | 28.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Dec 31, 2024 | 24.00 Mn |
| Dec 31, 2024 | 24.00 Mn |
| Sep 30, 2024 | 27.00 Mn |
| Sep 30, 2024 | 27.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 22.00 Mn |
| Mar 31, 2024 | 22.00 Mn |